Table 1.
UC with neoplasia (n=19) | UC without neoplasia (n=23) | |
---|---|---|
Sex | ||
Female | 5 (26%) | 11(48%) |
Male | 14 (74%) | 12(52%) |
| ||
Race | ||
African American | 2 (11%) | 2 (9%) |
Asian | 1 (5%) | 1 (4%) |
Caucasian | 16 (84%) | 20(87%) |
| ||
Ethnicity | ||
Hispanic | 0 | 2 (9%) |
Not Hispanic | 19 (100%) | 21 (91%) |
| ||
Median Age (IQR) | 49.1 years (40.4–59.3) | 51.7 years (38.5–57.1) |
| ||
Median Disease | 17.3 (12.9–23.7) | 22.1 years (13–33.3) |
Duration | ||
| ||
PSC | 3 (16%) | 0 |
| ||
Medications | ||
Mesalamine | 12 | 15 |
Immunomodulator | 2 | 6 |
Anti-TNF | 0 | 4 |
Anti-integrin | 1 | 0 |
None | 4 | 1 |
| ||
Disease Extent | ||
Left-sided | 3 (16%) | 5 (22%) |
Pancolitis | 16 (84%) | 18 (78%) |